Article | November 30, 2022

Do You Have A Combination Product, And Is It Drug-Led Or Device-Led?

Source: Premier Consulting

By Ryan Key, PhD, Manager, RA CMC

science drug development data iStock-1209661917

With the promise of simplified and improved treatments, the $118 billion combination-product market is projected to increase at a compound annual growth rate (CAGR) of 8.8%. Working to bring these valuable new therapies to patients, sponsors engaged in strategic development often approach Premier Consulting for regulatory clarification: “Is this actually a combination product? What do we need to do if it is?” They realize that proceeding down the wrong development pathway risks precious time and money, so it’s crucial to identify what kind of combination products they have, from the start.

This blog post aims to bring clarity to this confusing subject for sponsors.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Delivery Leader